Oyster Point Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Oyster Point Pharma, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $3.02 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2022-11-10
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.02M.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $2.01M.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $10.53M.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $20.46M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2022-09-30 | $3.02M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.01M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10.53M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $20.46M 10-K · filed 2022-02-24 |
| 2021-09-30 | $14.88M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $23.73M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $24.18M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $23.91M 10-K · filed 2021-02-18 |
| 2020-09-30 | $25.58M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $34.28M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $40.37M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $24.76M 10-K · filed 2020-02-27 |